Inspire Medical Systems I...

NYSE: INSP · Real-Time Price · USD
86.96
2.38 (2.81%)
At close: Aug 15, 2025, 1:13 PM

Inspire Medical Systems Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
802.8M 624.8M 407.86M 233.39M
Cost of Revenue
122.99M 96.58M 66.11M 33.28M
Gross Profit
679.82M 528.22M 341.74M 200.12M
Operating Income
36.08M -40.27M -47.59M -39.85M
Interest Income
23.25M 20.56M 5.05M 125K
Pretax Income
58.45M -19.91M -44.27M -41.97M
Net Income
53.51M -21.15M -44.88M -42.04M
Selling & General & Admin
529.61M 451.96M 320.69M 202.62M
Research & Development
114.13M 116.54M 68.64M 37.35M
Other Expenses
n/a n/a -49K -117K
Operating Expenses
643.74M 568.49M 389.33M 239.97M
Interest Expense
22K n/a 1.68M 2.13M
Selling & Marketing Expenses
n/a 100.3M 74.3M 47.8M
Cost & Expenses
766.72M 665.07M 455.45M 273.24M
Income Tax Expense
4.94M 1.25M 613K 72K
Shares Outstanding (Basic)
29.76M 29.3M 28.07M 27.26M
Shares Outstanding (Diluted)
30.54M 29.3M 28.07M 27.26M
EPS (Basic)
1.80 -0.72 -1.6 -1.54
EPS (Diluted)
1.75 -0.72 -1.6 -1.54
EBITDA
65.03M -17.06M -39.69M -38.62M
EBIT
58.48M -19.91M -42.59M -39.84M
Depreciation & Amortization
6.55M 2.85M 2.9M 1.99M